Ronald M. Nordmann is Director at PAR PHARMACEUTICAL COMPANIES, INC. (PRX). They have made 3 open-market trades across 1 company since 2007, most recently 2012-09-28.
CIK 0001189790
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $37K since 2007, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PRX | 4,000 | — |
Shares reported on the most recent Form 4, priced at the 2012-03-21 close. 1 holding could not be priced and is excluded from the total.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.